FDA Import Refusal AEK-0646196-5/10002/1 — Boehringer Ingelheim Pty Limited
The FDA refused shipment AEK-0646196-5/10002/1 from Boehringer Ingelheim Pty Limited (Australia) on Jul 23, 2026. The refused product falls under Drugs and Biologics — AFOXOLANER (ANTIPARASITIC). Cited charge: 72 This firm has 4 other import refusals on record.
Refusal details
- Date
- Jul 23, 2026
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 60ZLY01 AFOXOLANER (ANTIPARASITIC)
- Charges
- 72